ITGAM and neoplasm: We also confirmed by immunohistochemistry the increase in Ly6C+ cells and by immunofluorescence the decrease of CD11b+ myeloid cells and F4/80+ macrophages in MC38 tumor samples following fruquintinib treatment in another independent experiment (Supplementary Figures 9, 10).